Drug – bio-affecting and body treating compositions – Effervescent or pressurized fluid containing – Organic pressurized fluid
Patent
1988-01-25
1992-05-05
Page, Thurman
Drug, bio-affecting and body treating compositions
Effervescent or pressurized fluid containing
Organic pressurized fluid
424422, 514 2, 514885, A61K 9127
Patent
active
051106000
ABSTRACT:
Retrovirally-infected cells are selectively killed as compared with uninfected cells using an effective amount of amino acid analogs of naturally occurring amino acids, such as L-canavanine (an analog of arginine).
REFERENCES:
patent: 3804776 (1974-04-01), Yazawa et al.
patent: 4185090 (1980-01-01), McIntire
patent: 4338335 (1982-07-01), McAleer et al.
patent: 4377567 (1982-03-01), Geho
patent: 4400295 (1983-08-01), Odtsu et al.
patent: 4638045 (1987-01-01), Kohn et al.
patent: 4713244 (1987-12-01), Bawa et al.
patent: 4717716 (1988-01-01), Nagai et al.
patent: 4744989 (1988-05-01), Payne et al.
patent: 4752425 (1988-06-01), Martin et al.
patent: 4755388 (1988-07-01), Heath et al.
patent: 4761288 (1988-08-01), Mezei
patent: 4774320 (1988-09-01), Tagliabue et al.
patent: 4795739 (1989-01-01), Lifson et al.
patent: 4855090 (1989-08-01), Wallach
patent: 4871488 (1989-10-01), Mannino et al.
patent: 4883661 (1989-11-01), Daly et al.
Mitsuya et al., "Strategies for antiviral therapy in AIDS" Nature, 325:773-778 (1987).
G. A. Rosenthal, "The biological effects and mode of action of L-Canavanine, a structural analogue of L-Arginine", Qt. Rev. Biol., 52:155-178 (1977).
Cummings et al., "Structural aberations in T-even bacteriophage. ill. induction of lollipops and their partial characterization", Virology 54:245-261 (1973).
Schachtele et al., "Canavanine death in Escherichia coli", J. Mol. Biol., 14:474-489 (1965).
Neurath et al., "Inhibition of adenovirus replication by Canavanine", Biochem. Biophys. Res. Commun., 41: 1509-1517 (1970).
McMahon et al., "The effects of Canavanine and arginine starvation on macromolecular synthesis in Chlamydomonas reinhardi", J. Gen. Microbiol., 73:239-250 (1972).
Kruse et al., "Incorporation of Canavanine into protein of Walker carcinosarcoma 256 cells cultured in Vitro", Cancer Res., 19:122-125 (1959).
Dahlman et al., "Further studies of the effect of L-Canavanine on the tobacco hornworm, Manduca sexta", J. Insect Physiol., 22:265-271 (1976).
D. Bell, "The effect of Canavanine on herpes simplex virus replication", J. Gen. Virol., 22:319-330 (1974).
W. F. Prouty, "Degradation of abnormal proteins in HeLa cells", J. Cell Physiol., 88:371-382 (1976).
Goldberg et al., "Intercellular protein degradation in mammalian and bacterial cells: part 2", Ann. Rev. Biochem., 45:747-803 (1976).
Green et al., "Antitumor activity of L-Canavanine against L1210 Murine leukemia", Cancer Research 40:535:537 (1980).
Berjis et al., "Selective cytotoxicity of L-Canavanine in tumorigenic Madin-Darby canine kidney T.sub.1 cells", Interactions, 60:305-315 (1986).
Thomas et al., "Growth inhibition of a rat colon tumor by L-Canavanine", Cancer Research, 46:2898-2903 (1986).
Malinow et al., "Systemic lupus erythematosus-like syndrome in monkeys fed alfalfa sprouts: role of a nonprotein amino acid", Science, 216:415-417 (1982).
B. D. Noe, "Inhibition of islet prohormone to hormone conversion by incorporation of arginine and lysine analogs", J. Biol. Chem., 250:7623-7630 (1975).
Christner et al., "Inhibition of the assembly and secretion of procollagen by incorporation of a Thereonine analogue, Hydroxynorvaline", J. Biol. Chem., 250:7623-7630 (1975).
Green et al., "Enhancement of human tumor cell killing by L-Canavanine in combination with .gamma.-radiation", Cancer Res., 43:4180-4182 (1983).
Thomas et al., "Toxicity and pharmacokinetics of the nonprotein amino acid L-Canavanine in the rat", Toxicology and Applied Pharmacology, 91:395-405 (1987).
Yarchoan et al., "Development of antiretroviral therapy for the acquired immunodeficiency syndrome and related disorders", New England J. of Med., 316(9):557-563 (1987).
Kaplan et al., "Treatment of patients with acquired immunodeficiency syndrome and associated manifestations", JAMA, 257(10): 1367-1374 (1987).
Naha et al., "Reappraisal of L-Canavanine as an anti-tumor agent", Cell Biology Internatl. Rpts., 4(2) 155-165 (1980).
Mandel SaraLynn
Page Thurman
The Regents of the University of California
LandOfFree
Method of treating viral infections with amino acid analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating viral infections with amino acid analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating viral infections with amino acid analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1411237